文献速递胸部肿瘤放疗放疗物理与技术姑息放疗与转移瘤

自适应放疗计划与再程放疗软件模块的评估

Evaluation of a software module for adaptive treatment planning and re-irradiation.
PubMed 文献 · Radiat Oncol · 2017-12-28

研究评估动态计划模块在放疗工作流程中的可用性与接受度,一年内370例患者用于计划适应或再程放疗,其中肺癌亚组20例分析发现38%意外需要适应,PTV平均变化12±12%,再计划可降低患侧肺平均剂量。

要点

  • 动态计划模块用于计划适应与再程放疗决策,医师和物理师接受度高。
  • 肺癌亚组中38%计划病例意外需要适应,PTV平均变化12±12%。
  • 再计划在15/20例中降低患侧肺平均剂量。

核心结论

  • 动态计划模块在科室使用一年显示医师和物理师接受度高。
  • 再计划可能降低危及器官累积剂量并改善靶区覆盖。
  • 再程放疗时该工具可考虑前次剂量、更具体调整当前方案并审核累积剂量。

研究设计与样本

  • 单中心一年内370例计划适应或再程放疗患者按治疗身体区域分类。
  • 对20例肺癌放疗患者亚组详细评估计划适应的剂量学效应。
  • 评估肿瘤体积变化、再计划频率及治疗开始至计划适应的时间间隔。

主要发现

  • 动态计划工具每年用于20%的治疗患者,其中42%为计划适应、58%为再程放疗。
  • 病例评估以胸部区域最多(51%),其次盆腔(21%)和头颈(10%)。
  • 肺癌亚组中38%的计划病例意外进行了计划适应,治疗首日至需适应中位时间17天(范围4-35天)。
  • PTV平均变化12±12%(最大变化42%),20例中18例因肿瘤缩小而减小、2例增大。
  • 再计划使20例中15例患侧肺平均剂量降低。

临床怎么用

  • 可在放疗疗程中利用该模块判断是否需要计划适应。
  • 再程放疗时可利用该模块估算前次治疗区域剂量并计算危及器官累积剂量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this work is to validate the Dynamic Planning Module in terms of usability and acceptance in the treatment planning workflow. METHODS: The Dynamic Planning Module was used for decision making whether a plan adaptation was necessary within one course of radiation therapy. The Module was also used for patients scheduled for re-irradiation to estimate the dose in the pretreated region and calculate the accumulated dose to critical organs at risk. During one year, 370 patients were scheduled for plan adaptation or re-irradiation. All patient cases were classified according to their treated body region. For a sub-group of 20 patients treated with RT for lung cancer, the dosimetric effect of plan adaptation during the main treatment course was evaluated in detail. Changes in tumor volume, frequency of re-planning and the time interval between treatment start and plan adaptation were assessed. RESULTS: The Dynamic Planning Tool was used in 20% of treated patients per year for both approaches nearly equally (42% plan adaptation and 58% re-irradiation). Most cases were assessed for the thoracic body region (51%) followed by pelvis (21%) and head and neck cases (10%). The sub-group evaluation showed that unintended plan adaptation was performed in 38% of the scheduled cases. A median time span between first day of treatment and necessity of adaptation of 17 days (range 4-35 days) was observed. PTV changed by 12 ± 12% on average (maximum change 42%). PTV decreased in 18 of 20 cases due to tumor shrinkage and increased in 2 of 20 cases. Re-planning resulted in a reduction of the mean lung dose of the ipsilateral side in 15 of 20 cases. CONCLUSION: The experience of one year showed high acceptance of the Dynamic Planning Module in our department for both physicians and medical physicists. The re-planning can potentially reduce the accumulated dose to the organs at risk and ensure a better target volume coverage. In the re-irradiation situation, the Dynamic Planning Tool was used to consider the pretreatment dose, to adapt the actual treatment schema more specifically and to review the accumulated dose.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Richter A, Weick S, Krieger T, et al. Evaluation of a software module for adaptive treatment planning and re-irradiation. Radiat Oncol. 2017. PMID: 29282089. doi:10.1186/s13014-017-0943-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。